Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNα-2b and topical imiquimod 5% cream

International Journal of Dermatology

Volumn 48, Issue 2, 2009, Pages 214-215

  Turan, Aysegul ^a   Saricaoglu, Hayriye ^a   Baskan, Emel Bulbul ^a   Toker, Semra Cikman ^a   Tunali, Sukran ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; IMIQUIMOD;

ADULT; BASAL CELL CARCINOMA; CASE REPORT; DISEASE DURATION; EDEMA; EROSION; ERYTHEMA; FEMALE; FLU LIKE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LETTER; PUNCH BIOPSY; REMISSION; SKIN CRUST; SKIN DISEASE; TELANGIECTASIA; TREATMENT DURATION; VESICULATION;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERON ALFA-2B; MIDDLE AGED; NOSE NEOPLASMS; SKIN NEOPLASMS;

EID: 59149086098     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.03576.x     Document Type: Letter

References (10)

1. Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for basal cell carcinoma. J Am Acad Dermatol 1992; 26: 117-120.
2. Cornell RC, Greenway HT, Tucker SB, et al. Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990; 23 (4 Part 1): 694-700.
3. Buechner S, Wernli M, Bachmann F, et al. Intralesional interferon in basal cell carcinoma: How does it work? Recent Results Cancer Res 2002; 160: 246-250.
4. Testerman TL, Gerster JF, Imbertson LM, et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 1995; 58: 365-372.
5. Shumack S, Robinson J, Kossard S, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma. Comparison of dosing regimens. Arch Dermatol 2002; 138: 1165-1171.
6. Sterry W, Ruzicka T, Herrera E, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: Randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 2002; 147: 1227-1236.
7. Geisse J, Caro I, Lindholm J, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722-733.
8. Vidal D, Matias-Guiu X, Alomar A. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. Exp Dermatol 2004; 29: 518-525.
9. Kim KH, Yavel RM, Gross VL, et al. Intralesional interferon α-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited. Dermatol Surg 2004; 30: 116-120.
10. Greenway HT, Cornell RC, Tanner DJ, et al. Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol 1986; 15: 437-443.